Although I describe myself as a dividend growth investor, even more fundamentally, I consider myself a buy and hold investor. I've learned that overconfident investors and money managers trade more often, thus increasing transaction costs, and decreasing returns. Despite being close to pulling the trigger on a couple buys over the several weeks, nothing really caught my attention enough to convince me to buy into a stock.
My most likely next two purchases are adding to my positions in Microsoft and Pfizer. Both stocks are trading near 52-week highs, so I'll sit back and wait for some bad news on either company. Hopefully, it'll pay to be patient.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.